ABCC8 p.Arg168Cys
[switch to full view]Comments [show]
None has been submitted yet.
No.
Sentence
Comment
46
Molecular genetic analysis: Sequencing analysis showed that the infant was heterozygous for two missense mutations, R168C and G1256S, in exons 4 and 31 of the ABCC8 gene.
X
ABCC8 p.Arg168Cys 22796691:46:116
status: NEW47 The C>T mutation at nucleotide 502 (c.502C>T) results in substitution of cysteine for arginine at codon 168 (p.Arg168Cys) and has been reported previously in a patient with CHI [5].The G>Amutation at nucleotide 3766 (c.3766G>A) results in the substitution of serine for glycine at codon 1256 (p.Gly1256Ser), and has been identified in another patient with PNDM (Flanagan and Ellard, unpublished data).
X
ABCC8 p.Arg168Cys 22796691:47:73
status: NEWX
ABCC8 p.Arg168Cys 22796691:47:111
status: NEW48 Testing of parents showed that the father was heterozygous for the missense mutation G1256S while the mother was heterozygous for the missense mutation R168C, implying that father was a carrier of NDM while mother was a carrier of CHI.
X
ABCC8 p.Arg168Cys 22796691:48:152
status: NEW
PMID: 24686051
[PubMed]
Demirbilek H et al: "Clinical characteristics and phenotype-genotype analysis in Turkish patients with congenital hyperinsulinism; predominance of recessive KATP channel mutations."
No.
Sentence
Comment
67
The remaining six ABCC8 mutations, p.R168C, p.N188S, p.L533P, p.W232G, p.R842Q and p.F591L were each identified in a single patient.
X
ABCC8 p.Arg168Cys 24686051:67:37
status: NEW85 Gene Current age (year) Exon/intron DNA description Protein description Consequence Transmission Treatment Follow-up Developmental delay Comments Diazoxide responsive Octreotide responsive Pancreatectomy (histology) ABCC8 1 3.9 Exon 28 c.3554COA p.Ala1185Glu Missense Homozygous K C K Octreotide CCC Novel mutation 2 0.7 Exon 28 c.3554COA p.Ala1185Glu Missense Homozygous K C K Octreotide Novel mutation 3 9.1 Exon 28 c.3554COA p.Ala1185Glu Missense Homozygous K K K Irregular CCCC Novel mutation 4 0.7 Exon 28 c.3554COA p.Ala1185Glu Missense Homozygous K C K Octreotide C Novel mutation 5 0.2 Exon 28 c.3554COA p.Ala1185Glu Missense Homozygous K C K Octreotide Novel mutation 6 0.7 Exon 28 c.3512delT p.Leu1171fs Frameshift Homozygous K K C (diffuse) Remission 7 0.7 Exon 28 c.3512delT p.Leu1171fs Frameshift Homozygous K C C (diffuse) Octreotide 8 Died Exon 28 c.3512del p.Leu1171fs Frameshift Heterozygous paternal K K C (diffuse) Died 9 5.8 Exon 28 c.3512delT p.Leu1171fs Frameshift Homozygous K C K Octreotide CCC Ectodermal dysplasia 10 9.6 Exon 28 c.3512delT p.Leu1171fs Frameshift Homozygous K C K Octreotide CCC 11 0.7 Exon 4 c.502COT c.563AOG p.Arg168Cys/ p.Asn188Ser Missense Compound heterozygous K C C (diffuse) Octreotide K 12 Died Exon 10 c.1598TOC p.Leu533Pro Missense Homozygous K C K Died Novel mutation 13 10.6 Exon 5/ exon 21 c.694TOG/ c.2525GOA p.Trp232Gly/ p.Arg842Gln Missense/ Missense Compound heterozygous K C K Octreotide CC 14 5.5 Exon 12 c.1771TOC p.Phe591Leu Missense Heterozygous C K Diazoxide K KCNJ11 15 2.4 Exon 1 c.101GOA/ c.376GOA p.Arg34His/ p.Glu126Lys Missense/ Missense Compound heterozygous K C K Octreotide K 16 3.3 Exon 1 c.272GOA p.Trp91X Nonsense Homozygous K C C (diffuse) Octreotide CC 17 3.2 Exon 1 c.376GOA p.Glu126Lys Missense Homozygous K C C (diffuse) Octreotide CC HADH 18 4.4 Exon 6 c.706COT p.Arg236X Nonsense Homozygous C Diazoxide C Genotype-phenotype correlation " Comparison between KATP mutation-positive and KATP mutation-negative groups highlighted a statistically significant increased birth weight and younger age of presentation in KATP mutation-positive group as compared with KATP mutation-negative patients (Table 3).
X
ABCC8 p.Arg168Cys 24686051:85:1155
status: NEW